These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 36747205)

  • 1. Empagliflozin suppressed cardiac fibrogenesis through sodium-hydrogen exchanger inhibition and modulation of the calcium homeostasis.
    Chung CC; Lin YK; Chen YC; Kao YH; Yeh YH; Trang NN; Chen YJ
    Cardiovasc Diabetol; 2023 Feb; 22(1):27. PubMed ID: 36747205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiological testosterone attenuates profibrotic activities of rat cardiac fibroblasts through modulation of nitric oxide and calcium homeostasis.
    Chung CC; Lin YK; Kao YH; Lin SH; Chen YJ
    Endocr J; 2021 Mar; 68(3):307-315. PubMed ID: 33115984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor Xa inhibition by rivaroxaban regulates fibrogenesis in human atrial fibroblasts with modulation of nitric oxide synthesis and calcium homeostasis.
    Chung CC; Lin YK; Chen YC; Kao YH; Yeh YH; Chen YJ
    J Mol Cell Cardiol; 2018 Oct; 123():128-138. PubMed ID: 30213724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Class effects of SGLT2 inhibitors in mouse cardiomyocytes and hearts: inhibition of Na
    Uthman L; Baartscheer A; Bleijlevens B; Schumacher CA; Fiolet JWT; Koeman A; Jancev M; Hollmann MW; Weber NC; Coronel R; Zuurbier CJ
    Diabetologia; 2018 Mar; 61(3):722-726. PubMed ID: 29197997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Empagliflozin Ameliorates Ouabain-Induced Na
    Peng X; Li L; Lin R; Wang X; Liu X; Li Y; Ma C; Ruan Y; Liu N
    Cardiovasc Drugs Ther; 2023 Jun; 37(3):461-469. PubMed ID: 34982348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast Growth Factor 23 Stimulates Cardiac Fibroblast Activity through Phospholipase C-Mediated Calcium Signaling.
    Lee TW; Chung CC; Lee TI; Lin YK; Kao YH; Chen YJ
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Empagliflozin Attenuates Myocardial Sodium and Calcium Dysregulation and Reverses Cardiac Remodeling in Streptozotocin-Induced Diabetic Rats.
    Lee TI; Chen YC; Lin YK; Chung CC; Lu YY; Kao YH; Chen YJ
    Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30987285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelial growth factor enhances profibrotic activities through modulation of calcium homeostasis in human atrial fibroblasts.
    Chung CC; Lin YK; Chen YC; Kao YH; Lee TI; Chen YJ
    Lab Invest; 2020 Feb; 100(2):285-296. PubMed ID: 31748680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Empagliflozin decreases myocardial cytoplasmic Na
    Baartscheer A; Schumacher CA; Wüst RC; Fiolet JW; Stienen GJ; Coronel R; Zuurbier CJ
    Diabetologia; 2017 Mar; 60(3):568-573. PubMed ID: 27752710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The sodium-glucose co-transporter 2 inhibitor empagliflozin attenuates cardiac fibrosis and improves ventricular hemodynamics in hypertensive heart failure rats.
    Lee HC; Shiou YL; Jhuo SJ; Chang CY; Liu PL; Jhuang WJ; Dai ZK; Chen WY; Chen YF; Lee AS
    Cardiovasc Diabetol; 2019 Apr; 18(1):45. PubMed ID: 30935417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium Regulation on the Atrial Regional Difference of Collagen Production Activity in Atrial Fibrogenesis.
    Chung CC; Lin YK; Chen YC; Kao YH; Yeh YH; Chen YJ
    Biomedicines; 2021 Jun; 9(6):. PubMed ID: 34204537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Empagliflozin prevents oxidative stress in human coronary artery endothelial cells via the NHE/PKC/NOX axis.
    Li X; Wang M; Kalina JO; Preckel B; Hollmann MW; Albrecht M; Zuurbier CJ; Weber NC
    Redox Biol; 2024 Feb; 69():102979. PubMed ID: 38061206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sodium-glucose cotransporter 2 inhibitors antagonize lipotoxicity in human myeloid angiogenic cells and ADP-dependent activation in human platelets: potential relevance to prevention of cardiovascular events.
    Spigoni V; Fantuzzi F; Carubbi C; Pozzi G; Masselli E; Gobbi G; Solini A; Bonadonna RC; Dei Cas A
    Cardiovasc Diabetol; 2020 Apr; 19(1):46. PubMed ID: 32264868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sodium-glucose cotransporter 2 inhibitor Dapagliflozin attenuates diabetic cardiomyopathy.
    Arow M; Waldman M; Yadin D; Nudelman V; Shainberg A; Abraham NG; Freimark D; Kornowski R; Aravot D; Hochhauser E; Arad M
    Cardiovasc Diabetol; 2020 Jan; 19(1):7. PubMed ID: 31924211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Empagliflozin inhibits Na
    Trum M; Riechel J; Lebek S; Pabel S; Sossalla ST; Hirt S; Arzt M; Maier LS; Wagner S
    ESC Heart Fail; 2020 Dec; 7(6):4429-4437. PubMed ID: 32946200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NHE-1 participates in isoproterenol-induced downregulation of SERCA2a and development of cardiac remodeling in rat hearts.
    Shibata M; Takeshita D; Obata K; Mitsuyama S; Ito H; Zhang GX; Takaki M
    Am J Physiol Heart Circ Physiol; 2011 Nov; 301(5):H2154-60. PubMed ID: 21856903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct Effects of Empagliflozin on Extracellular Matrix Remodelling in Human Cardiac Myofibroblasts: Novel Translational Clues to Explain EMPA-REG OUTCOME Results.
    Kang S; Verma S; Hassanabad AF; Teng G; Belke DD; Dundas JA; Guzzardi DG; Svystonyuk DA; Pattar SS; Park DSJ; Turnbull JD; Duff HJ; Tibbles LA; Cunnington RH; Dyck JRB; Fedak PWM
    Can J Cardiol; 2020 Apr; 36(4):543-553. PubMed ID: 31837891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute SGLT-2i treatment improves cardiac efficiency during myocardial ischemia independent of Na
    Baker HE; Tune JD; Mather KJ; Blaettner BS; Clark HE; Li F; Li X; Kowala MC; Fliegel L; Goodwill AG
    Int J Cardiol; 2022 Sep; 363():138-148. PubMed ID: 35753619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Empagliflozin reduces oxidative stress through inhibition of the novel inflammation/NHE/[Na
    Uthman L; Li X; Baartscheer A; Schumacher CA; Baumgart P; Hermanides J; Preckel B; Hollmann MW; Coronel R; Zuurbier CJ; Weber NC
    Biomed Pharmacother; 2022 Feb; 146():112515. PubMed ID: 34896968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Empagliflozin, a sodium glucose co-transporter-2 inhibitor, alleviates atrial remodeling and improves mitochondrial function in high-fat diet/streptozotocin-induced diabetic rats.
    Shao Q; Meng L; Lee S; Tse G; Gong M; Zhang Z; Zhao J; Zhao Y; Li G; Liu T
    Cardiovasc Diabetol; 2019 Nov; 18(1):165. PubMed ID: 31779619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.